Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Current Opinion in Immunology|January 15, 2016
Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibitionPeter Kar Han Lau, Paolo A Ascierto, Grant McArthur
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 23, 2003
Applications of positron emission tomography in the development of molecular targeted cancer therapeuticsBenjamin Solomon, Grant McArthur, Carleen Cullinane, et al.
BMJ Case Reports|November 25, 2016
Glucocorticoids did not reverse type 1 diabetes mellitus secondary to pembrolizumab in a patient with metastatic melanomaJasna Aleksova, Peter K H Lau, Georgia Soldatos, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
New Era in the Management of Melanoma Brain MetastasesHussein A Tawbi, Celine Boutros, David Kok, et al.
PET Clinics|January 17, 2024
Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin MalignanciesSze-Ting Lee, Natalia Kovaleva, Clare Senko, et al.
Frontiers in Oncology|March 13, 2015
Phenotype switching in melanoma: implications for progression and therapyFrederic Zhentao Li, Amardeep Singh Dhillon, Robin L Anderson, et al.
Health Science Reports|April 3, 2019
Bevacizumab as a steroid-sparing agent during immunotherapy for melanoma brain metastases: A case seriesPatricia D Banks, Arian Lasocki, Peter K H Lau, et al.
Plos One|July 11, 2013
CDC25B overexpression stabilises centrin 2 and promotes the formation of excess centriolar fociRose Boutros, Odile Mondesert, Corinne Lorenzo, et al.
Internal Medicine Journal|September 20, 2020
Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID-19 pandemicCraig Underhill, Phillip Parente, Grant McArthur, et al.
Pageof 10